Key facts
- Himaging Technology’s last known valuation is $10.8M (Jan 2020).
- It has raised $2.2M; the latest was Later Stage VC in Aug 2025.
- Notable investors include Suzhou Mingcheng Venture, Bison Capital Financial Holdings, Mihe Investment, Origins Capital, TigerYeah Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Himaging Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Himaging Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Himaging Technology
Developer of diagnostic imaging equipment intended for clinical visualization and procedural guidance. The company offers single-use endoscopic devices with enhanced image processing, multi-scale texture structure enhancement, hemoglobin visualization, and electronic chromo features, serving healthcare providers in urology, respiratory, and otolaryngology fields to reduce cross-contamination risks, improve diagnostic accuracy, and streamline operational efficiency through cost-effective, high-performance imaging tools.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2016
- Website
- himaging.com/
- Ownership
- Privately Held (backing)
Himaging Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Himaging Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Himaging Technology in its N-PORT filings yet. We sweep new filings monthly.